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Abstract
We employ targeted mass spectrometry to compare the levels of H2AX S139 phosphorylation (γH2AX) 
and Y142 phosphorylation. We use synthetic peptides to facilitate MS optimization and estimate
relative detection efficiencies for the different modifications. Despite phosphopeptide enrichment
from large amounts of starting material, we are unable to detect endogenous H2AX Y142
phosphorylation, indicating that it is present at low abundance (<1%). We also calculate the relative
levels of H2AX compared to other H2A isoforms and quantify the proportion of H2AX that is
phosphorylated on S139 (γH2AX) after ionizing radiation.  
Introduction
S139 phosphorylation
The histone H2A family variant, H2AX, is distinguished from canonical H2A family members through a
22 amino acid C-terminal tail [1]. Phosphorylation of the C-terminal domain of H2AX at position 139
(γH2AX) is a rapid response to DNA double-strand breaks (DSB). S139 is phosphorylated by ATM, ATR 
and DNA-PK, which are phosphatidylinositol 3-kinase-related kinases. γH2AX foci are widely used as 
diagnostic markers of DSB. The utility of γH2AX as a marker stems from the rapid (<1 min) and 
extensive nature of this modification. Rogakou et al. observed that approximately 1% of total H2AX
becomes phosphorylated per gray of ionizing radiation (IR), and extrapolated from H2AX relative
abundance that each DSB results in γH2AX covering on average 2 million bp [2]. The biological function 
of such large γH2AX domains is not clear, and the H2AX histone is not essential for DSB repair, however 
H2AX-/-mice show increased ionizing radiation sensitivity, as well as increases in chromatid breaks and
dicentric chromosomes [3].
Y142 phosphorylation
The H2AX C-terminal domain can also be phosphorylated on tyrosine 142 by the WSTF remodelling
factor kinase [4-6]. Cook et al. show that dephosphorylation of Y142 upon DNA damage avoids
apoptosis. Using synthetic phosphopeptides, they demonstrate binding of pro-apoptotic factors to
S139 Y142 doubly-phosphorylated peptides: the implication is that Y142 phosphorylation is abundant,
and will be located in proximity to DNA damage. While kinases and phosphatases responsible for
creating and removing this modification have been identified, the basal level of Y142 phosphorylation
is unknown, although our earlier intact histone MS analysis indicates that in HeLa cells it is not greater
than ~10% [7]. Scully et al. expressed epitope-tagged H2AX in H2AX-/- mouse ES cells and identified a
number of H2AX modifications by mass spectrometry, including S139 and T101 phosphorylation,
however Y142 phosphorylation was not detected [8]. The role of Y142ph in the DNA damage response
is of great interest, with the identification of putative interacting proteins that recognise the doubly
phosphorylated C-terminal tail [9]. Mutation of these residues has been carried out in the chicken
DT40 cell line and revealed that Y142A IR sensitivity is rescued by co-mutation of S139A [10].
H2AX levels across cell lines and in the genome
Given the role of H2AX phosphorylation in signalling DNA damage and recruiting repair proteins, it is
interesting to consider the levels of H2AX present across the genome in human cells. Rogakou et al.
employed two-dimensional gel separation of histone preparations with Coomassie staining to quantify
H2AX as a proportion of all H2A1, H2A2 and H2AX signal. They analysed four human cell lines and
found H2AX makes up 2-25% of the total [2].
Materials and methods
Synthetic peptides and recombinant histones
Peptides listed below were synthesized by JPT (Germany).
Synthetic Peptide Sequence
GHYAERATQASQEY KGHYAERGKTGGKAR GKTGGKARAKAKSR
GHYAERATQA-pS-QEY KGNYAERGKTGGKAR GKQGGKARAKAKSR
GHYAERATQASQE-pY-
Recombinant H2AX and H2A1B were expressed in E. coli Rosetta 2(DE3) pLysS. Cultures were
incubated at 37C with 180 rpm agitation. Unlabelled proteins were grown in 2YT media to OD600 0.6
and induced with isopropyl--D-thiogalactoside (IPTG) for 4 h before harvest. 15N-labelled proteins
were produced using a two-step expression procedure. 2YT cultures were grown to OD600 0.6 and cells
collected by centrifugation. Cells were gently resuspended in an equivalent volume of pre-warmed
minimal media (50 mM Na2HPO4, 50 mM KH2PO4, 1 g/L (
15NH4)2SO4, 2 mM MgSO4, 20 mM citric acid,
30 mg/L thiamine, pH7.0) and incubated at 37C for 30min prior to IPTG induction for 4 h and harvest.
Recombinant histones were purified according to the established inclusion body wash procedure
followed by cation exchange chromatography [11]. Purified histones were dialysed into water and
lyophilised for long term storage. The recombinant proteins were resuspended in water at a
concentration of 2mg/ml, based on absorbance at 278 nm using extinction coefficients 5960 and 4470
M-1cm-1 for H2AX and H2A1B, respectively. MS analysis of 15N H2AX indicated that labelling was >98%
complete. Recombinant histone sequences are shown below. Synthetic peptide sequences are
underlined.
H2AX:
MSGRGKTGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGHYAERVGAGAPVYLAAVLEYLTAEILELAGNAARDNK
KTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTSATVGPKAPSGGKKATQASQEY
H2A1B:
MSGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYSERVGAGAPVYLAAVLEYLTAEILELAGNAARDNK
KTRIIPRHLQLAIRNDEELNKLLGRVTIAQGGVLPNIQAVLLPKKTESHHKAKGK
Cell lines and cell culture: Human U2-OS and HeLa cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% foetal calf serum, 2mM L-glutamine, 100 U/ml penicillin,
and 100 μg/ml streptomycin. Epstein Barr virus-transformed wild-type lymphoblastoid cells (LCLs; a 
gift fromMark O’Driscoll; [12]) were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium
supplemented with 15% foetal calf serum, 2mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml 
streptomycin. Approximately 6x107 cells were grown for each sample.
Irradiating Cells: U2-OS cells were irradiated with a dosage of 20 Gy using a 137Cs source. Cells were
immediately placed in a 37°C incubator and were left to recover for either 5 minutes, 30 minutes, or
60 minutes. Upon recovery, cells were spun down and were immediately flash frozen and stored at -
80°C before sample preparation.
Nuclei Isolation and Acid Extraction: Nuclei Isolation Buffer 250 (NIB-250) was prepared: 15 mM Tris
HCl (pH 7.5), 60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 1 mM CaCl2, and 250 mM Sucrose. NIB-250 was
supplemented with the following phosphatase and protease inhibitors: 10 mM Na-butyrate, 0.5 mM
AEBSF, 2 μM leupeptin, 1 μM Pepstatin A, 1 μM aprotonin, 2 mM PMSF, 50 mM NaF, 2 mM Na-
orthovanadate, and 60 mM β-glycerophosphate. NIB-250 with 0.3% NP-40 was added to the cells at a 
ratio of 10:1. Cells were incubated on ice for 5 min and then subsequently spun down at 600 rcf for
five min at 4°C. The supernatant was discarded and then NIB-250 without NP-40 was added to the cell
pellet and spun down again, twice. The remaining pellet consisted of isolated nuclei. The isolated
nuclei was vortexed slowly and 0.4N sulphuric acid was added to the cells at a final ratio of 5:1. The
nuclei-H2SO4 suspension was left to incubate on ice for 60 minutes and then spun down at the
centrifuge’s maximum speed for 5 minutes at 4°C. The supernatant was transferred to a
microcentrifuge tube. To the supernatant, 100% trichloroacetic acid (TCA) was added to give a final
concentration of 20% TCA. The mixture was left to precipitate overnight at 4°C. The precipitate was
then spun down at the microcentrifuge’s maximum speed. The pellet was resuspended in chilled
acetone with 0.1% hydrochloric acid. The sample was then spun down, washed twice with acetone,
left to air dry, and finally dissolved in water.
Derivitisation and Trypsinisation: Amodified version of the derivatization protocol described inMaile
et al. was employed [13]. From the acid extracted histone sample, 5 μg was used to make up a volume 
of 9 μl. 1 μL of 1M tetraethylammonium bromide (TEAB) was added to the sample to buffer the 
subsequent reaction. 1 μL of diluted propionic anhydride (in water to a ratio of 1:100) was added to 
the histones. The samples were vortexed for 2 minutes at room temperature. To quench the
derivitisation reaction, 1 μL of 80 mM hydroxylamine was added and the samples were left to incubate 
for 20 minutes at room temperature. The pH of the samples was measured to ensure optimal trypsin
digestion, ~pH8.5. 250 ng of trypsin was added to each sample and left to digest at 37°C for 4 hours
or overnight. Upon digestion, a second round of derivitisation was carried by adding 3 μL of 1:100 
diluted propionic anhydride. The samples were vortexed for 2 minutes at room temperature. 3 μL of 
80 mM hydroxylamine was then added to quench the second round of derivitisation.
Phosphopeptide enrichment: TiO2 metal oxide affinity chromatography was approximately as
described in Matheron et al. [14]. Briefly, TiO2 beads (Titansphere; 5 μm; GL Sciences, Japan) were 
resuspended at 10 mg/ml in 30% acetonitrile (ACN), 0.1% TFA. 50 μL of this slurry was packed by 
centrifugation (400g) into a GELoader tip spin column (Eppendorf; 0.5-20 μL volume) fritted with a C8 
filter membrane (Empore). The spin column was equilibrated with loading buffer (80% ACN, 6% TFA;
50 μl at 2,200), the sample was loaded (2 x 50 μL; 200g) and the column washed twice (50 μL; 50% 
ACN, 0.5% TFA, 0.2MNaCl; 500g), with salt omitted in the secondwash. Phosphopeptides were eluted
with 20 μL of 10% NH4OH (200g), into 25 μL 10% FA. A final elution of 3 μL 80% ACN, 2% FA was 
employed to release peptides from the C8 frit. Further acid (3 μL FA) was added to the eluates. Eluates 
were dried in a vacuum centrifuge and resuspended in 10 μL 0.1% TFA.  
Nano-LC/MS: Peptide samples were analyzed by nano-LC-MS (ThermoFisher U3000 nanoLC and
Orbitrap XL mass spectrometer). Peptides were loaded onto a C18 trapping cartridge (Pepmap100
C18; 0.3 x 5 mm i.d.; 5 μm particle size) for 5 min at a flow-rate of 5 μL/min in 0.1% TFA loading buffer. 
Peptides were separated on an analytical column (PepMap100; 25 cm x 75 μm; 5 μm particle size) by 
a gradient from 1 to 35% ACN over 28 min, in the presence of 0.1% FA, at a flow rate of 0.3 μL/min. 
Time 0 15 25 28 28 35 35
% acetonitrile 1 12 35 60 90 90 1
Nanospray was from a New Objective emitter with 10 μm tip (FS360-20-10-N-20). Pseudo-SRM was 
carried out in the linear ion trap of an Orbitrap XL, with a precursor isolation window of 2 m/z, an ion-
trap fill time of maximum 50 ms and an LTQ target ion count of 1E4 [15]. A high-resolution precursor
scan was carried out in the Orbitrap (5E5 target). Total cycle time was <30 s, enabling sufficient points
across eluting peptide peaks for quantitation. For the TiO2-enrichment eluates, in addition to the
targeted LTQ events, a data-dependent event was included, to enable identification of untargeted
enriched phosphopeptides.
Pseudo-SRM creation and analysis: Skyline v3.1 (MacCoss Lab, University of Washington) was used
for both development of pseudo SRM methods and for data analysis [16]. Peptide sequences for
protein of interest were obtained from Uniprot and entered into Skyline. Putative and known post-
translational modifications of interest were added to the peptides. Predicted b and y ions were
surveyed on the instrument. To distinguish between different isobaricmasses at least three transitions
were selected that were unique to each peptide. Transitions used for data analysis are listed in
Supplementary Table 1.
Data analysis
Database searching for the TiO2-enriched samples employed Mascot and the Swissprot database.
Settings were as follows: twomissed cleavages; precursor 5 ppm error; fragment 0.6 Da error; variable
modifications of acetylation (K), mono-, di- and trimethylation (K), phosphorylation with neutral loss
(S,T), phosphorylation (Y). Three U2-OS acid extract TiO2 eluates (25 μg, 50 μg, 50 μg + Y142ph peptide) 
were run as a combined search. Mascot results were filtered to require expectation value <0.05 and
bold red and exported as .csv. The peptide list was sorted according to descending E-value and
duplicate pep_scan_titles were removed. 1393 peptide identifications remained. Duplicates in all
three of pep_seq and pep_var_mod and pep_var_mod_pos were removed (again removing lowest E-
value duplicates). 456 identifications remained. 307 of these were phosphorylated (including spiked
Y142ph peptide). Some were clearly false-positives (as expected given E-value 0.05): filtering to
require E-value <0.01 leaves 370 identifications, of which 230 were phosphorylated.
Results
In order to develop sensitive selected reaction monitoring (SRM) assays for H2AX phosphopeptide
detection by mass spectrometry, as employed previously for histone H3 methylation analysis [17], we
designed synthetic peptides containing either phosphorylated Y142, phosphorylated S139 or no
modification. To allow determination of relative ionization efficiency, these peptides were synthesized
concatenated with a common quantification peptide. After trypsin digestion to separate the two
peptides, the released phosphopeptides were fragmented (Figure 1a), and the indicated fragments
were quantified in pseudo-SRM assays utilising the linear ion trap of an Orbtrap XL [15]. The H2AX C-
terminal peptides were detected in both singly- and doubly-charged forms. The singly-charged species
was preferred for sensitive detection of low levels of C-terminal peptide in the presence of abundant
canonical histone peptides, due to low background in this m/z region for these transitions. The
released H2AX-specific quantification peptide (GHYAER) acts as an internal standard: the ionization
efficiency of the C-terminal peptide is measured relative to the quantification peptide in each case
(Figure 1b). We found that the phosphorylated peptides were detected 2.6x and 8.3x less well than
the unphosphorylated peptide (S139ph and Y142ph, respectively; Figure 1b).
Figure 1. a) MS/MS fragmentation of singly-charged ATQASQEY S139 or Y142 phosphorylated
precursors. Fragment ions used for quantitation are underlined. b) Concatenated synthetic peptides
allow assessment of relative detection efficiency after trypsin digestion, nanoLC separation and
pseudo-SRM peptide fragmentation. Both N-terminal and C-terminal peptides are unique to H2AX.
Error bars show standard deviation (n=3).
We apply this correction factor to data obtained from U2-OS cells after ionizing radiation (IR) to
estimate that approximately 75% of H2AX in the sample was phosphorylated at S139 60 minutes after
20 Gy IR (Figure 2).
Figure 2. Quantification of γH2AX Ser139 phosphorylation after DNA damage. A) Time-course after
20 Gy IR (U2-OS). Fragment ions from the singly-charge unmodified and S139 phosphorylated
precursors were quantified. Mean of two biological replicates is shown, each of which was analysed
in technical triplicate. Error bars show standard deviation. Data shown is uncorrected for detection
efficiency.
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We did not detect Y142ph in undamaged cells or any of the time-points shown in Figure 2. We
considered that the failure to detect Y142 phosphorylation in our histone preparations could indicate
that this modification is present only at low abundance, given that we were able to detect the
synthetic Y142ph peptide with reasonable sensitivity. We therefore carried out a TiO 2 metal oxide
affinity phosphopeptide enrichment step on a histone preparation from undamaged U2-OS cells,
which we had shown to contain only low levels of γH2AX phosphorylation (approximately 4%). We 
carried out a parallel enrichment on a control sample, containing 50 pmol BSA and 0.5 pmol of α-
casein, Y142ph, S139ph and unmodified synthetic peptides (Figure 3). We see efficient enrichment of
Y142ph, S139ph from the control sample, in addition to the expected α-casein phosphopeptides. We 
also see efficient enrichment of S139ph from the undamaged U2-OS sample, alongside a number of
other phosphopeptides from other histones and low-level phosphoproteins present in the acid-
extract. However no Y142ph signal was detected from the U2-OS sample.
Figure 3. TiO2-based phosphopeptide enrichment of H2AX C-terminal peptides. A) Successful
enrichment of S139ph and Y142ph peptides from 100x excess BSA peptides B) Enrichment of
endogenous S139ph peptide from undamaged U2-OS, relative to the unmodified peptide. LHS:
quantification of fragment ions from singly-charged precursors. RHS: precursor ions (with relative
intensity shown).
To further verify that there was no technical problemwith our enrichment, we spiked Y142ph peptide
(2 pmol) into a U2-OS sample (50 μg acid extract). Enrichment from the spiked sample was carried out 
in parallel with enrichment from an equivalent unspiked sample. As before, endogenous S139ph was
enriched in both cases. Y142ph was successfully enriched from the spiked sample, but not detectable
in the unspiked sample (Figure 4). Although the U2-OS acid extracts contain mainly histones, TiO2
enrichment allowed identification of 232 distinct phosphopeptides (with an expectation value <0.01),
mainly from low abundance non-histone proteins (Supp. table 2). These identifications included the
previously described CDK3 Y15 tyrosine phosphorylation. In addition to H2AX S139ph, previously
reported core histone phosphorylations H3 S10ph, S57ph and H4 S47ph were also identified, as well
as nine H1 sites.
Figure 4. Successful enrichment of Y142ph synthetic peptide spiked into U2-OS acid extract. 0.1% of
the 50 μg sample was analysed pre-enrichment; both Y142ph (synthetic) and S139ph are barely 
detectable using pseudo-SRM (precursor ions are not detectable; data not shown). After enrichment
both H2AX phosphopeptides are detected with good signal-to-noise.
H2AX abundance across cell lines
We compared the abundance of two peptides unique to H2AX (GKTGGKAR and KGHYAER) to similar
peptides in other H2A family members in three cell lines: U2-OS, HeLa and an EBV-transformed
lymphoblastoid cell line (LCL; Table 1). In this analysis we employed a propionylation derivatization
step prior to, and after, trypsin digestion. In order to control for possible variations between sample
preparations, 15N-labelled recombinant H2AX and H2A1B were spiked into the three samples. These
samples were then derivatized and digested as normal and analysed in technical triplicate. Figure 5
shows the normalized ratio of endogenous H2AX to 15N H2AX peptide for each cell line, indicating U2-
OS contains the highest relative abundance of H2AX, >2x more than HeLa. The two H2AX peptides
both give similar results.
Figure 5. Relative amount of H2AX across three cell lines. 15N recombinant H2AX and H2A1B were
spiked into U2-OS, HeLa and LCL extracts; ratios for diagnostic peptides were calculated and
normalised to ratio of H2A1B GKQGGKAR, to control for small differences in starting acid extract
amounts. Error bars show standard deviation.
H2AX abundance compared to other H2A family variants
We quantified the signal from the two peptides unique to H2AX as a proportion of the signal from
closely related H2A family peptides (Figure 6 and Table 1). Concatenated peptides were again
employed to correct for detection efficiencies, as above. The same trend with respect to H2AX
abundance across the three cell lines is observed, as expected (U2-OS>LCL>HeLa). The estimates of
H2AX abundance are not identical for the two different H2AX peptides. The proportion of H2AX
calculated from the KGHYAER peptide is consistently higher than that calculated from the GKTGGKAR
peptide, This difference may be due to the different ionization properties of the non-canonical
peptides (KGNYSER and GKQGGKVR), synthetic versions of which were not available for correction.
Importantly, both peptides give a highly similar relative abundance across the three cell lines. The
values shown in Table 1 represent upper estimates, as four divergent H2A variants are not measured
at all.
Figure 6. Quantification of H2AX abundance relative to other H2A isoforms. Relative H2AX levels
(corrected for detection efficiency) from U2-OS, HeLa and LCL. Quantification is of fragment ions from
doubly-charged precursors. Data is from two biological replicates, analysed in technical triplicate.
KGHYAER is unique to H2AX; KGNYSER is unique to H2A 1B, 1D and 3. Error bars show standard
deviation.
Measured
peptide Protein(s) U2OS HeLa LCL
GKTGGKAR H2AX 4 (0.7) 1 (0.6) 2 (0.03)
GKQGGKAR
11 H2A (1A, 1B, 1C, 1H, 1J, 1D, 1, 2A,
2C, 3, 2B) 96 (0.6) 98 (0.9) 98 (0.2)
GKQGGKVR H2AJ 1 (0.05) 1 (0.3) 0 (0.1)
not measured H2AB1, H2AB2, H2AV, H2AZ n.m. n.m. n.m.
Total 17 100 100 100
KGHYAER H2AX 6 (0.8) 3 (0.3) 5 (0.5)
KGNYAER 9 H2A (1A, 1C, 1H, 1J, 1, 2A, 2C, 2B, J) 87 (4.2) 88 (3.1) 83 (5.7)
KGNYSER H2A 1B, 1D, 3 7 (5.0) 9 (2.8) 12 (6.2)
not measured H2AB1, H2AB2, H2AV, H2AZ n.m. n.m. n.m.
Total 17 100 100 100
H2AX average 5 2 4
Table 1. H2AX abundance relative to H2A familymembers.GKTGGKARwas found to be detected 1.1x
better than the canonical version, GKQGGKAR. The H2AX peptide KGHYAER was detected 1.7x better
than the canonical version KGNYAER. The proportions are corrected accordingly in the table above.
Data is from two biological replicates, analysed in technical triplicate. The standard deviation is shown
in brackets.
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Discussion
We have developed pseudo-SRM assays to quantify levels of H2AX C-terminal phosphorylation. The
C-terminal phosphopeptides of H2AX are not the most straight-forward peptides to analyse in
positive-mode mass spectrometry, being without basic residues to balance the negative charge of the
phosphate group. Nonetheless, both S139ph and Y142ph peptides ionize to give doubly- and singly-
charged species, which can be fragmented to give diagnostic fragment ions. The two phosphopeptides
show considerable difference in retention time, avoiding co-fragmentation of the isobaric species. We
detect variable levels of γH2AX (S139ph) from undamaged U2-OS (4% and 12% in the two biological 
replicates contributing to Figure 2), increasing to 75% 1 h after 20 Gy IR and correction for detection
efficiency. We note that this level of S139ph is substantially higher than that previously reported by
Rogakou et al. (30-50%), albeit using a different method and for different cell lines [2]. Our correction
factor controls for ionization efficiency and fragmentation efficiency of the unmodified and
phosphorylated peptides, however it does not control for differences in trypsin release of the
measured peptides. We consider it possible that phosphorylation of S139 may affect the ability of
trypsin to cleave the proximal lysine, producing the quantified fully tryptic peptide: a set of synthetic
peptides incorporating the endogenous trypsin cleavage site would enable this to be tested
(APSGGKKATQASQEY). The 75% estimate should therefore be treated with caution.
We were unable to detect endogenous H2AX Y142ph, even after enrichment of phosphopeptides
from large amounts of histone preparations (50 μg). Notably, synthetic Y142ph was detected and 
enriched without difficulty. Given that after enrichment we identify endogenous S139ph from
undamaged cells (approximately 5% abundance) with a signal to noise ratio of over 100, we should be
able to identify S139ph at 20-40x lower abundance, i.e. 0.25-0.125% abundance within the genome.
Our synthetic peptide data indicates that the Y142ph peptide is detected 3.2 x less well than the
S139ph peptide, implying a conservative detection level of 0.8% overall abundance. Large-scale
phosphoproteomic studies have similarly failed to detect Y142ph, even when S139 phosphorylation
was detected, and in the absence of DNA damage treatments [18, 19]. We conclude that the
stoichiometry of Y142ph is low, at least below 1% of H2AX in undamaged U2-OS. Of the early papers
describing H2AX Y142ph, Krishnan et al. also used U2-OS cells [6]. It is possible that Y142ph levels are
higher in the other cell lines studied previously (HEK 293T, mouse 3T3 and mouse embryonic
fibroblasts). However if Y142 phosphorylation plays a significant physiological role in apoptosis and
the DNA damage response, it seems unlikely to vary dramatically across cell lines or between human
and mouse.
This low stoichiometry has implications for the use of Y142ph antibodies: Xiao et al. raised an antibody
that appears to strongly prefer Y142ph, but nevertheless still binds unphosphorylated Y142 (ELISA
Xiao et al. Supp. Fig. 1). With >100:1 ratio of unmodified to Y142ph, this background could be
problematic [4]. The low abundance of Y142ph also has implications for models involving binding of
proteins to both S139ph and Y142ph simultaneously [5, 9]: co-localisation of S139ph and Y142ph on
the same H2AX C-terminal tail would be most likely to occur at extremely high levels of DNA damage,
when the majority of H2AX S139 is phosphorylated. Analysis of the role of Y142 through site-directed
mutagenesis [10] is complicated by the observation that Y142 mutation interferes with binding of
proteins such as MDC1 to γH2AX [20].  
Removal of WSTF, the kinase responsible for Y142 phosphorylation, reduces γH2AX formation and 
abrogates the DNA damage response, however it is unclear if this is related to H2AX Y142
phosphorylation or to the chromatin remodelling role of this factor [4]. Our results would be
consistent with an indirect effect.
We analyse H2AX abundance in three cell lines, and find that H2AX constitutes between 2-5% of the
thirteen H2A family members quantified: the total level would therefore be lower when the remaining
four, more divergent, variants are taken into account (H2AV, H2AZ, H2AB1, H2AB2). This level seems
reasonable, considering that the gene encoding H2AX, H2AFX, is one of 24 H2A family (H2AF) genes,
encoding 17 unique H2A isoforms (Uniprot curated protein family). Therefore if all expression levels
were even, H2AX would make up 4.2% of cellular H2A.
Our estimate for HeLa of 1.8% H2AX is very similar to that of Rogakou et al. (2.4%) [2]. Presumably the
divergent H2A family members do not co-migrate with the canonical H2As upon two-dimensional gel
electrophoresis, and therefore were also not quantified by Rogakou et al.
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